Testing effectiveness (Phase 2)Study completedNCT01222689
What this trial is testing
Selumetinib and Erlotinib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage III Pancreatic Cancer+1 more
National Cancer Institute (NCI) 46